|
CCCC
|
C4 Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.04%
|
US
|
NASDAQ
|
|
AMRN
|
Amarin Corporation plc
|
0.04%
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
0.04%
|
US
|
NASDAQ
|
|
DYN
|
Dyne Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
BVS
|
Bioventus Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
0.03%
|
US
|
NASDAQ
|
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PAHC
|
Phibro Animal Health Corporation
|
0.03%
|
US
|
NASDAQ
|
|
OMER
|
Omeros Corporation
|
0.03%
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MGTX
|
MeiraGTx Holdings plc
|
0.03%
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.03%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|